Nasdaq

Nexentis Technologies Inc.

Pharmaceutical PreparationsCIK 0001789192New York, New YorkFilings at SEC EDGAR

At a glance

Most recent filing on October 22, 2026 — a grant by Itzhaik Asaf on Oct 15, 2026.

We hold 9 Form 4 lines, going back to October 19, 2026.

Insider trades

5 of 9 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 9. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Itzhaik Asaf Director
14,795 sharesGrant
TradedOct 15, 2026FiledOct 22, 2026
Palach David Chief Executive Officer
101,549 sharesGrant
TradedOct 15, 2026FiledOct 19, 2026
Barda Lital Chief Financial Officer
51,000 sharesGrant
TradedOct 15, 2026FiledOct 19, 2026
Berenstein Israel Yakov Director
19,375 sharesGrant
TradedOct 15, 2026FiledOct 19, 2026
Weiss Amitay Director
101,549 sharesGrant
TradedOct 15, 2026FiledOct 19, 2026